Artículo

Nonalcoholic steatohepatitis pharmacotherapy and predictors of response: dual role of aminotransferases as biosensors of metabolism and biomarkers of histological improvement

Sookoian, Silvia CristinaIcon ; Pirola, Carlos JoséIcon
Fecha de publicación: 08/2019
Editorial: AME Publishing Company
Revista: HepatoBiliary Surgery and Nutrition
ISSN: 2304-3881
e-ISSN: 2304-389X
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:

Resumen

Nonalcoholic steatohepatitis (NASH)—the severe histological form of nonalcoholic fatty liver disease (NAFLD)—is regarded as a major health problem worldwide (1,2). The disease can progress to liver cirrhosis and eventually to hepatocellular carcinoma (1,3). Treatment of NASH and NASH-fibrosis is thus increasingly being given priority in the clinical field.
Palabras clave: NAFLD , SYSTEMS BIOLOGY , PHARMACOTYHERAPY , ALT , AST , GPT , GOT
 
Archivos asociados
Thumbnail
 
Tamaño: 1.487Mb
Formato: PDF
.
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Atribución-NoComercial-SinDerivadas 2.5 Argentina (CC BY-NC-ND 2.5 AR)
Identificadores
URI: http://hdl.handle.net/11336/105342
URL: http://hbsn.amegroups.com/article/view/24474
DOI: https://dx.doi.org/10.21037/hbsn.2019.02.04
Colecciones
Articulos(IDIM)
Articulos de INST.DE INVEST.MEDICAS
Citación
Sookoian, Silvia Cristina; Pirola, Carlos José; Nonalcoholic steatohepatitis pharmacotherapy and predictors of response: dual role of aminotransferases as biosensors of metabolism and biomarkers of histological improvement; AME Publishing Company; HepatoBiliary Surgery and Nutrition; 8; 4; 8-2019; 381-385
Compartir
Altmétricas